SEC Form 4 · accession 0001140361-16-058244
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Douglas
Officer — President and COO ResMed Inc.
Period of report
Mar 16, 2016
Accepted (ET)
Mar 17, 2016 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1,F2 | Mar 16, 2016 | A | 4,680 | $0.00 | A | 80,291 | I | Douglas Family Trust |
| ResMed Common Stock | Mar 16, 2016 | F | 2,333 | $0.00 | D | 77,958 | I | Douglas Family Trust |
| ResMed Common Stock | holding | — | — | — | 31,304 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted March 1, 2013, with a three-year performance period. The shares were earned and vested March 16, 2016, when the ResMed compensation committee certified performance.
- F2Shares earned, based on performance, at 40% of the target award.
- F3Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted March 1, 2013.